Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Gene mutation
100%
Bortezomib
100%
Gene Overexpression
100%
Bortezomib Resistance
100%
PSMB5
100%
Proteasome Subunits
100%
Overexpression
33%
Molecular Mechanism
16%
Clinical Efficacy
16%
Gene Expression
16%
Small Interfering RNA (siRNA)
16%
Anticancer Drugs
16%
Drug Resistance
16%
Resistant Cells
16%
Novel Mechanism
16%
Cross-resistance
16%
Acquired Resistance
16%
THP-1 Cells
16%
Protease Inhibitors
16%
Chymotrypsin
16%
Resistance Trends
16%
Cytotoxic Peptide
16%
Relapsed or Refractory multiple Myeloma
16%
Binding Pocket
16%
Proteasome Activity
16%
Myelomonocytic
16%
PSMA7
16%
MG132
16%
PSMB7
16%
PSMB6
16%
Biochemistry, Genetics and Molecular Biology
Gene Mutation
100%
Proteasome
100%
Gene Overexpression
100%
Gene Expression
25%
Anticancer
25%
Drug Resistance
25%
Small Interfering RNA
25%
Cross Resistance
25%
Proteasome Inhibitor
25%
Chymotrypsin
25%
MG132
25%
Neuroscience
Bortezomib
100%
Gene Mutation
100%
Proteasome
100%
Gene Overexpression
100%
Gene Expression
11%
Drug Resistance
11%
Anticarcinogen
11%
Small Interfering RNA
11%
Chymotrypsin
11%
Proteasome Inhibitor
11%
Immunology and Microbiology
Gene Mutation
100%
Proteasome
100%
Gene Overexpression
100%
Gene Expression
20%
Drug Resistance
20%
Multiple Myeloma
20%
Cross-Resistance
20%